Pasteur Institute Nha Trang recruits volunteers to test the nasal spray COVID-19 vaccine

Trinh Thi Bich Thuy, director of the Center for Training – Scientific Management – International Cooperation, Pasteur Institute Nha Trang (located in Khanh Hoa), said that the unit continues to recruit volunteers to test vaccines against vaccines. COVID-19 nasal spray uses influenza virus vectors.

Pasteur Institute Nha Trang plans to recruit 3,000 volunteers aged 18 and over, living in two provinces of Quang Nam and Khanh Hoa to participate in phase III of the clinical research process of a nasal spray COVID-19 vaccine. , using the influenza virus vector.

Volunteers must meet additional requirements: healthy or stable mildly ill; last dose of COVID-19 vaccine given at least 3 months ago; never had COVID-19 and was willing to comply with the study’s 4 visits.

The volunteer recruitment program takes place from now until the end of April 30, 2022. The time for volunteers to participate in the trial is expected to last one year from the day the COVID-19 vaccine is sprayed into the body.

When registering, volunteers will be sampled for testing and health check; then sprayed with two experimental doses of the COVID-19 vaccine into the nose, 14 days apart, and monitored for one year with 4 regular visits according to the research program. Volunteers will be supported 900,000 VND/health visit.

“Clinical trial phases I and II of the influenza virus vector-based nasal spray COVID-19 vaccine trial have demonstrated good safety and immunogenicity. The study was reviewed. reviewed and approved by management agencies at all levels and the Ethics Council in biomedical research”, Ms. Thuy said.

People wishing to apply for a job can directly contact the health centers of the districts, towns and cities where they are living; Pasteur Institute Nha Trang, Center for Disease Control of Quang Nam Province, or contact for consultation via hotline phone numbers of two doctors Dao The Anh 0914.481.086 and Nguyen Tat Hoa 0379.657.671.

Jointly deploying the phase III nasal spray COVID-19 vaccine laboratory trial, currently in 5 countries, namely Colombia, Philippines, South Africa, Indonesia and Vietnam.